Table 2 Correlation of FGD5-AS1 expression with clinical and pathological characteristics of gastric cancer patients
Variables | Number of patients (30) | Low expression (15) | High expression (15) | P-value |
|---|---|---|---|---|
Sex | ||||
Male | 24 | 12 | 12 | 0.99 |
Female | 6 | 3 | 3 | |
Age | ||||
≤ 60 | 18 | 8 | 10 | 0.4561 |
> 60 | 12 | 7 | 5 | |
Tumor diameter | ||||
< 5 cm | 12 | 8 | 4 | 0.1360 |
> 5 m | 18 | 7 | 11 | |
T | ||||
1–2 | 8 | 1 | 7 | 0.0132 |
3–4 | 22 | 14 | 8 | |
N | ||||
0 | 9 | 3 | 6 | 0.0053 |
1–3 | 21 | 12 | 9 | |
M | ||||
0 | 27 | 12 | 15 | 0.0679 |
1 | 3 | 3 | 0 | |
Serous membrane infiltration | ||||
No | 11 | 2 | 9 | 0.008 |
Yes | 19 | 13 | 6 | |
Differentiation degree | ||||
Moderately differentiated | 12 | 7 | 5 | 0.4561 |
Poorly differentiated | 18 | 8 | 10 | |
Anatomic stage/prognostic groups | ||||
I&II | 13 | 3 | 10 | 0.0099 |
III&IV | 17 | 12 | 5 | |